You are here

GLP-1

Chinese insulin maker says its GLP-1 beat Ozempic at lowering blood sugar, body weight in phase 2

Fierce Biotech

Wed, 10/16/24 - 12:17 pm

type 2 diabetes

57 Million Eligible For GLP-1 Drug Coverage In U.S. And That’s Just Those Under 65

Forbes

Thu, 09/5/24 - 10:29 pm

New research could ease concerns over suicide risk of obesity drugs

BioPharma Dive

Tue, 09/3/24 - 05:58 pm

African drugmaker Aspen bets on GLP-1 drugs to boost profit

Reuters

Tue, 09/3/24 - 05:54 pm

GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study

BioSpace

Mon, 07/8/24 - 11:49 am

How the Ozempic gold rush is causing ‘deeply concerning’ shortage for diabetes patients

Biopharma Reporter

Wed, 03/13/24 - 11:16 am